Connect your agent to akta.pro and build company lists like this across sectors and geos.
This dashboard ranks the 30 most recent qualifying healthcare companies in the United States with new CEO hires during the stated window, using complete LG01 coverage and company-HQ verification. Rows add industry, firmographics, estimated revenue, funding, mandate and article sources.
| # | Date | Company | Industry / category | Firmographics | Est. revenue | Funding | Executive appointment | Mandate | Sources |
|---|---|---|---|---|---|---|---|---|---|
| 01 | Sep 24, 2026 | Cedar Health Research↗ Private · Founder Individual Operated Bootstrapped | Clinical Research Services Healthcare & Life Sciences Life Science Tools & Services | Dallas, US Founded 2020 · 11-50 emp. | $5M-$10M | — | Jody Staggs Chief Executive Officer | Strategy & Transformation Cedar Health Research appointed Jody Staggs as CEO, effective September 14, 2026. He previously led SWK Holdings, a life sciences holding company. Cedar operates five clinical research sites in the Dallas-Fort Worth metroplex, focusing on underrepresented patient populations. | PR Newswire 1 source |
| 02 | Sep 23, 2026 | Ascension Health↗ Private · Nonprofit Foundation Owned | Hospital Healthcare Services Healthcare & Life Sciences Healthcare Providers & Systems | St Louis, US Founded 1999 · 10001+ emp. | — | — | Justin Morley Chief Executive Officer | Strategy & Transformation Ascension, operating 91 hospitals across 36 states, made 37 executive moves in 2026, including appointments and departures. The changes cover roles such as CEO, president, and chief medical officer across multiple hospital systems. | BeckershospitalreviewYahoo 2 sources |
| 03 | Sep 23, 2026 | MUSC Health↗ Private · State Government Owned | Academic Medical Center (Healthcare Services) Healthcare & Life Sciences Healthcare Providers & Systems | Charleston, US Founded 1824 · 5001-10000 emp. | $5B+ | — | Jason Cox Chief Executive Officer | Strategy & Transformation MUSC Health named Jason Cox CEO of its Pee Dee Division in Florence, S.C., effective Sept. 22. He will lead four facilities, including Florence Medical Center and Marion Medical Center, and has five years of MUSC Health experience, most recently as interim CEO. | Beckershospitalreview 1 source |
| 04 | Sep 23, 2026 | The Joint Commission↗ Private · Nonprofit Foundation Owned | Healthcare Accreditation Services Healthcare & Life Sciences Public Health, Government & Regulators | Oak Brook, US Founded 1951 · 1001-5000 emp. | $500M-$1B | — | Jonathan Perlin Chief Executive Officer | Strategy & Transformation Joint Commission CEO Jonathan Perlin will retire at the end of 2026, with COO James Merlino succeeding as president and CEO on Jan. 1, 2027. Perlin will remain as strategic advisor and president emeritus. Merlino plans to focus on outcomes-based certification and workforce challenges. | Beckershospitalreview 1 source |
| 05 | Sep 22, 2026 | Memorial Healthcare System↗ Private · State Government Owned | Hospital Healthcare Services Healthcare & Life Sciences Healthcare Providers & Systems | Hollywood, US Founded 1953 · 5001-10000 emp. | $1B-$5B | — | Stephen Demers Chief Executive Officer | Strategy & Transformation Stephen Demers was promoted to CEO of Memorial Hospital West in Pembroke Pines, Fla., according to a Sept. 21 LinkedIn post from Memorial Healthcare System. He has served as CEO of Memorial Hospital Miramar since June 2023 and previously held operations roles at the University of Miami Health System. | BeckershospitalreviewBeckershospitalreview +3 more 5 sources |
| 06 | Sep 22, 2026 | Cadence Neuroscience↗ Private · Venture Growth Investor Backed | Neuromodulation Medical Devices Healthcare & Life Sciences Medical Devices & Diagnostics | Redmond, US Founded 2017 · 11-50 emp. | Pre-revenue | — | Chris Cronin Chief Executive Officer | Strategy & Transformation Cadence Neuroscience appointed Chris Cronin as CEO and Kent Leyde as CTO, with Cronin bringing nearly three decades of medtech leadership. The company is preparing for clinical evaluation of its Biomarker Targeted Stimulation system in focal drug-resistant epilepsy, its first indication. | Prweb 1 source |
| 07 | Sep 21, 2026 | Light Wave↗ Private · Private Equity Controlled | Dental Practice Management Services Healthcare & Life Sciences Dental Care Services | Woodbridge, US Founded 2014 · 501-1000 emp. | $100M-$250M | — | Justin Jory Chief Executive Officer | Strategy & Transformation Lightwave Dental appointed Dr. Clifton Cameron as CEO effective October 1, 2026, succeeding founder Justin Jory. The company grew from 8 practices and $23 million revenue to over 100 practices and $300 million revenue. Jory will remain a shareholder and advisor. | FinancialContent Business Page 1 source |
| 08 | Sep 19, 2026 | Waikiki Health↗ Private · Nonprofit Foundation Owned | Community Health Center Services Healthcare & Life Sciences Healthcare Providers & Systems | Honolulu, US Founded 1967 · 101-250 emp. | $25M-$50M | — | David Kahananui Chief Executive Officer | Strategy & Transformation David Kahananui was named CEO of Waikiki Health, effective Oct. 1, bringing FQHC operations experience from Nevada and Arizona. He succeeds Mary Beth Lohman, who served as interim CEO since Alexis Charpentier stepped down. The board expects him to navigate potential federal funding and insurance eligibility changes. | American City Business Journals 1 source |
| 09 | Sep 18, 2026 | Summa Health↗ Private · Venture Growth Investor Backed | Integrated Healthcare Delivery Healthcare & Life Sciences Healthcare Providers & Systems | Akron, US Founded 1989 · 5001-10000 emp. | $1B-$5B | — | Jennifer Eslinger Chief Executive Officer | Strategy & Transformation Jennifer Eslinger will become president and CEO of Summa Health on Sept. 21, joining the $2.2 billion system after a $515 million acquisition by General Catalyst and HATCo. She will focus on operational efficiency and technology rollouts, aiming to improve SummaCare's cost control amid rising premiums and uncompensated care headwinds. | FierceHealthcareRbj +4 more
|
| 10 | Sep 18, 2026 | California Hospital Association↗ Private · Nonprofit Foundation Owned | Hospital Trade Association Services Business & Public Services Nonprofit, NGO & Social Services | Sacramento, US Founded 1935 · 101-250 emp. | $25M-$50M | — | Bryan Bucklew Chief Executive Officer | Strategy & Transformation The California Hospital Association named Bryan Bucklew as its next president and CEO, effective Oct. 26. Bucklew, who has over 20 years of hospital association experience, will succeed retiring CEO Carmela Coyle. The association represents nearly 400 member hospitals, health systems, networks, and other providers. | Beckershospitalreview 1 source |
| 11 | Sep 17, 2026 | Whitman Hospital and Medical Clinics↗ Private · State Government Owned | Rural Critical Access Hospital Services Healthcare & Life Sciences Healthcare Providers & Systems | Colfax, US Founded 1893 · 101-250 emp. | $25M-$50M | — | Hank Hanigan Chief Executive Officer | Strategy & Transformation Holly Shelden was named CEO of Whitman Hospital & Medical Clinics, succeeding interim CEO Hank Hanigan. She previously led Jefferson Community Health & Life in Nebraska. The hospital serves rural communities across 1,200 square miles. | Beckershospitalreview 1 source |
| 12 | Sep 16, 2026 | Oligomerix↗ Private · Venture Growth Investor Backed | Neurodegenerative Disease Therapeutics Healthcare & Life Sciences Pharmaceuticals | Bronx, US Founded 2006 · 1-10 emp. | Pre-revenue | — | Cara Cassino interim President and CEO | Strategy & Transformation Oligomerix appointed Cara Cassino as interim President and CEO, with its tau-targeting drug OLX-07010 clearing its first human safety trial. The company is advancing the oral compound into next clinical stages, targeting Alzheimer's and other tau-related diseases. | Longevity.TechnologyLongevity.Technology 2 sources |
| 13 | Sep 15, 2026 | Legend Biotech↗ Public | Cell Therapy Pharmaceuticals — Oncology Biologics Healthcare & Life Sciences Biotechnology & Biologics | Piscataway, US Founded 2014 · 1001-5000 emp. | $1B-$5B | — | Ingrid Zhang Chief Executive Officer | Strategy & Transformation Legend Biotech appointed Ingrid Zhang as CEO effective Sept. 15, 2026, succeeding Alan Bash, who will resume as President of CARVYKTI. Zhang previously served as Chief Commercial Officer at Novartis. The company plans to expand its cell therapy pipeline. | Stock TitanFierceBiotech +6 more
|
| 14 | Sep 15, 2026 | Franciscan Alliance↗ Private · Nonprofit Foundation Owned | Hospital and Outpatient Healthcare Services Healthcare & Life Sciences Healthcare Providers & Systems | Indianapolis, US Founded 1974 · 5001-10000 emp. | $1B-$5B | — | Kevin Leahy Chief Executive Officer | Strategy & Transformation Michael Englehart was named president and CEO of Mishawaka, Ind.-based Franciscan Alliance, effective Oct. 1. He will lead over 17,000 employees across 11 hospitals and the Franciscan Physician Network, succeeding Kevin Leahy, who will remain through Dec. 31. | Beckershospitalreview 1 source |
| 15 | Sep 15, 2026 | Truveta↗ Private · Venture Growth Investor Backed | Real-World Health Data Platform Healthcare & Life Sciences Digital Health & Health IT | Bellevue, US Founded 2020 · 251-500 emp. | $50M-$100M | — | Terry Myerson Chief Executive Officer | Strategy & Transformation Terry Myerson announced his retirement as CEO of Truveta, effective immediately, after six and a half years. Co-founders Jay Nanduri and Ryan Ahern will serve as interim co-CEOs while the board searches for a successor. The transition comes as Truveta enters its next phase of growth. | FinancialContent Business Page 1 source |
| 16 | Sep 15, 2026 | Wisp↗ Private · Corporate Owned | Women's Telehealth Healthcare & Life Sciences Telehealth Platforms | San Francisco, US Founded 2018 · 1-10 emp. | $10M-$25M | — | Keira Krausz Chief Executive Officer | Strategy & Transformation Wisp, the largest U.S. women's telehealth company, announced it has reached two million patients and named Keira Krausz CEO. The company, majority-owned by WELL Health Technologies, will expand into fertility, perimenopause, menopause, and at-home diagnostics. Krausz said the expansion is driven by patient feedback on unmet needs. | Inc. 1 source |
| 17 | Sep 14, 2026 | HCA Healthcare↗ Public | Acute Care Hospital Services Healthcare & Life Sciences Healthcare Providers & Systems | Nashville, US Founded 1960 · 10001+ emp. | $5B+ | — | Mike Hoyt Chief Executive Officer | Strategy & Transformation Mike Hoyt was appointed CEO of Riverside (Calif.) Community Hospital, an HCA Healthcare affiliate, after serving as COO since 2024. He previously held interim CEO roles and led operational departments at the 542-bed hospital, including seismic compliance planning. | BeckershospitalreviewAmerican City Business Journals +5 more
|
| 18 | Sep 14, 2026 | Harrison County Community Hospital↗ Private · State Government Owned | Critical Access Hospital Services Healthcare & Life Sciences Healthcare Providers & Systems | Bethany, US Founded 1951 · 11-50 emp. | $25M-$50M | — | Tina Gillespie Chief Executive Officer | Strategy & Transformation Tina Gillespie will step down as CEO of Harrison County Community Hospital on Oct. 3, with Nikki Hendren appointed interim CEO. Hendren has served as COO since April 2023. The hospital will maintain continuity of care during the transition. | Beckershospitalreview 1 source |
| 19 | Sep 14, 2026 | Providence↗ Private · Nonprofit Foundation Owned | Integrated Healthcare Delivery Healthcare & Life Sciences Healthcare Providers & Systems | Renton, US Founded 1856 · 10001+ emp. | $5B+ | — | Krissy Petersen Chief Executive Officer | Strategy & Transformation Krissy Petersen, a Deer Lodge native and former chief nursing officer, was named CEO of Providence Montana. She prioritizes rural care and quality, overseeing a cardiac institute expansion and drone-delivery research. She also noted the hospital's unionization and labor and delivery closure. | Billings Gazette 1 source |
| 20 | Sep 11, 2026 | Callio Therapeutics↗ Private · Venture Growth Investor Backed | Oncology Biopharmaceuticals (ADC Therapeutics) Healthcare & Life Sciences Biotechnology & Biologics | Seattle, US Founded 2025 · 1-10 emp. | Pre-revenue | — | Zachary Hornby Chief Executive Officer | Strategy & Transformation Callio Therapeutics appointed Zachary Hornby CEO to advance its dual-payload ADC pipeline. The company's lead candidate CLIO-8221 is in a Phase 1/2 trial for HER2-expressing tumors, with enrollment underway in Australia and the U.S. and plans to expand to China. | Pulse 2.0 1 source |
| 21 | Sep 11, 2026 | Keck Medicine of USC↗ Private · Nonprofit Foundation Owned | Academic Medical Center Services Healthcare & Life Sciences Healthcare Providers & Systems | Los Angeles, US Founded 1903 · 5001-10000 emp. | $1B-$5B | — | Rodney Hanners Chief Executive Officer | Strategy & Transformation Keck Medicine of USC named Steven Shapiro MD as CEO and Marty Sargeant as COO, effective Sept. 24. Shapiro, previously USC's senior vice president for health affairs, will oversee the health system and medical school, while Sargeant continues as CEO of Keck Medical Center. The changes aim to accelerate clinical and research expansion. | Beckershospitalreview 1 source |
| 22 | Sep 10, 2026 | Actithera↗ Private · Venture Growth Investor Backed | Radiopharmaceuticals Healthcare & Life Sciences Pharmaceuticals | Cambridge, US Founded 2021 · 11-50 emp. | Pre-revenue | — | Steven Kelly Chief Executive Officer | Strategy & Transformation Actithera appointed Steven Kelly as CEO and board member to advance its lead fibroblast activation protein-targeted radioligand therapy into clinical development. The Oslo and Cambridge-based company also named Briggs Morrison chair and John Crowley an independent director. Founder Andreas Goutopoulos remains president and head of R&D. | citybiz 1 source |
| 23 | Sep 10, 2026 | Boundary Community Hospital↗ Private · State Government Owned | Rural Community Healthcare Healthcare & Life Sciences Healthcare Providers & Systems | Bonners Ferry, US Founded 1955 · 101-250 emp. | $25M-$50M | — | April Bennett Chief Executive Officer | Strategy & Transformation Bryce Cordle, chief nursing officer, will become CEO of Boundary Community Hospital in Bonners Ferry, Idaho, effective October, succeeding April Bennett, who is retiring. Cordle brings nearly three decades of healthcare experience and will build on Bennett's leadership. | Beckershospitalreview 1 source |
| 24 | Sep 9, 2026 | Ennov↗ Private · Private Equity Controlled | Life Sciences Compliance Software Healthcare & Life Sciences Life Science Tools & Services | Greensboro, US Founded 2001 · 251-500 emp. | $50M-$100M | — | Oxana Pickeral Chief Executive Officer | Strategy & Transformation Ennov appointed Dr. Oxana Pickeral as CEO, with founder Olivier Pâris joining the board as strategic advisor. The company plans to embed AI across its platform and establish a North American delivery hub. Bregal Sagemount and Ardian invested in Ennov. | Business Wire Blog 1 source |
| 25 | Sep 9, 2026 | WW International↗ Public | Weight Management Services Home & Personal Services Fitness, Wellness & Personal Training | New York, US Founded 1963 · 1001-5000 emp. | $500M-$1B | — | Stephen Bye Chief Executive Officer | Strategy & Transformation WW International's stock fell 10% after appointing Stephen Bye as CEO, effective this fall. The company, facing weight-loss drug competition, has begun facilitating drug access. WW shares have declined 45% over the past year. | Tipranks 1 source |
| 26 | Sep 8, 2026 | CHRISTUS Health↗ Private · Nonprofit Foundation Owned | Integrated Healthcare Delivery Services Healthcare & Life Sciences Healthcare Providers & Systems | Irving, US Founded 1860 · 10001+ emp. | $5B+ | — | Grant Wicklund Chief Executive Officer | Strategy & Transformation Grant Wicklund will retire as CEO of Christus Santa Rosa Health System in San Antonio, Texas, after joining in 2023. During his tenure, the system expanded its hospital with 100 private beds and added neurosciences capacity. He previously led roles at Tenet Healthcare and Centura Health. | Beckershospitalreview 1 source |
| 27 | Sep 8, 2026 | Rose BioSolutions↗ Private · Private Equity Controlled | Cell and Gene Therapy CDMO Services Healthcare & Life Sciences Life Science Tools & Services | Memphis, US Founded 2026 · 501-1000 emp. | $250M-$500M | — | David Enloe Chief Executive Officer | Strategy & Transformation Rose BioSolutions appointed David Enloe as CEO, bringing over 35 years of biotech and pharma services experience. He previously led Introgen Therapeutics, founded Vivante GMP Solutions, and served as CEO of Societal CDMO and Ajinomoto Bio-Pharma Services. He aims to advance Rose Bio's end-to-end platform for cell and gene therapies. | PR Newswire 1 source |
| 28 | Sep 8, 2026 | STAAR Surgical Company↗ Public | Ophthalmic Medical Devices Healthcare & Life Sciences Medical Devices & Diagnostics | Lake Forest, US Founded 1982 · 251-500 emp. | $250M-$500M | — | David Bailey Chief Executive Officer | Strategy & Transformation STAAR Surgical appointed former CEO David Bailey as Chief Commercial Officer to drive EVO ICL growth amid a weakening laser refractive market. Bailey previously led STAAR from 2001-2008, raising over $60 million and securing FDA approval. He will report to CEO Warren Foust and join the ESCRS Congress in London. | Stock Titan 1 source |
| 29 | Sep 3, 2026 | William Newton Hospital↗ Private · Nonprofit Foundation Owned | Community Hospital Services Healthcare & Life Sciences Healthcare Providers & Systems | Winfield, US Founded 1927 · 251-500 emp. | $50M-$100M | — | Jason Anglin Chief Executive Officer | Strategy & Transformation Jason Anglin was named CEO of William Newton Hospital in Winfield, Kan., effective Aug. 31, succeeding Gigi Fergus as interim CEO. He brings 32 years of healthcare executive experience, including leading Monroe County Hospital and guiding five financial turnarounds. His early priorities include listening tours, financial analysis, and provider recruitment. | Beckershospitalreview 1 source |
| 30 | Aug 18, 2026 | Longevica↗ Private · Venture Growth Investor Backed | Longevity Therapeutics Healthcare & Life Sciences Pharmaceuticals | Princeton, US Founded 2009 · 1-10 emp. | Pre-revenue | — | Prasun Mishra Chief Executive Officer | Strategy & Transformation Longevica Therapeutics appointed Prasun Mishra, an ex-Genentech executive, as CEO to lead its preclinical longevity program. The company spent $13 million over four years screening 1,033 compounds in over 16,000 mice, identifying new lifespan-extension mechanisms. Mishra will advance these leads into clinical trials and seek partnerships. | Longevity.Technologycitybiz 2 sources |
This page treats a leadership hire as a source-grounded appointment, promotion, or explicit expansion into a senior operating role at an eligible company. The event must identify the executive and new title, fall inside the stated date window, and satisfy the requested leadership scope. For CEO, a keyword appearing only in the company name or surrounding article is not enough; the title or reported mandate must actually match the requested function.
Geography is assigned from the company's akta.pro record, not from a publisher location, article dateline, executive location, or News Signals country tag. That distinction matters because syndicated coverage of one appointment can carry different country labels. When an industry filter is requested, the company must also match the approved akta.pro industry taxonomy used for ListGen or Company Data. Revenue and funding are descriptive enrichment fields and never determine whether a company qualifies or how it ranks.
The ranking is company-level rather than article-level. Multiple articles about the same appointment are merged into one LG01 event, and multiple qualifying appointments at the same company are counted but collapsed to the newest event for the displayed row. Companies are ordered by appointment announcement date, then by the number of distinct supporting sources, then alphabetically. The initial ListGen coverage set is twice the requested list size, while the broad LG01 pull protects against missing a recent hire simply because the company was absent from that coverage sample. If fewer than the requested number qualify, the page shows the smaller verified set instead of weakening the evidence standard.
Companies are tagged against standard industry codes and against akta.pro's internal taxonomy, so the same set can be rebuilt by code, by segment, or by a combination of both.
NAICSIndustry codes are provided for cross-referencing against public filings and procurement records. akta.pro classification is independent of them, so a company may carry an internal segment without a matching NAICS or SIC registration.